Perphenazine in Host-Directed Immunomodulation & Neuropharma
2026-05-07
Explore how Perphenazine, a potent dopamine D2 receptor antagonist, uniquely bridges neuropharmacology with host-directed antibacterial strategies. This article reveals new mechanistic insights for mitochondria-mediated cell death and immunomodulation, empowering advanced assay development.
TPPU: Unveiling sEH Inhibition for Precision Lipidomics Rese
2026-05-06
Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, enables precision control of epoxyeicosatrienoic acids metabolism and fatty acid epoxide signaling. This article reveals cutting-edge insights on assay design and translational modeling, uniquely guiding researchers in chronic inflammation and redox biology.
Gene Expression Profiling Reveals HR Defects in Mesothelioma
2026-05-06
Borchert et al. (2019) systematically profiled homologous recombination (HR) gene expression in malignant pleural mesothelioma (MPM), uncovering that a subset of tumors with 'BRCAness' signatures are particularly susceptible to PARP inhibition. This work highlights the mechanistic link between HR pathway alterations, therapy resistance, and opportunities for precision combination therapies in MPM.
Anlotinib Hydrochloride: Precision Tools for Functional Angi
2026-05-05
Explore the unique multi-target action of Anlotinib hydrochloride—a potent tyrosine kinase inhibitor—on endothelial cell migration and angiogenesis. This article goes beyond standard reviews by decoding its assay-specific advantages and decision points for advanced cancer research.
Sulfo-NHS-SS-Biotin: Protocols and QC for Cleavable Labeling
2026-05-05
Sulfo-NHS-SS-Biotin is a water-soluble biotin disulfide N-hydroxysulfosuccinimide ester designed for efficient, amine-specific protein labeling in aqueous environments. It enables selective cell surface protein tagging for affinity purification or detection, with reversible label removal via disulfide cleavage. This reagent is not suitable for applications requiring stable intracellular protein labeling or extended solution stability.
Trametinib (GSK1120212): Applied Oncology Research Workflows
2026-05-04
Trametinib (GSK1120212) stands out as a highly potent, ATP-noncompetitive MEK1/2 inhibitor, empowering researchers to dissect the MEK-ERK pathway and its downstream effects on cell proliferation, apoptosis, and cell cycle regulation. This article translates the latest experimental and mechanistic findings—including APEX2/TERT regulation—into actionable protocols, troubleshooting guidance, and advanced applications for oncology and stem cell studies.
Technical Guide: FITC-Concanavalin A (ConA) Conjugate Use
2026-05-04
FITC-Concanavalin A (ConA) Conjugate addresses the challenge of specifically detecting α-D-glucose and α-D-mannose residues on cell surfaces in immunofluorescence and flow cytometry workflows. It should not be used for non-carbohydrate-binding assays or outside its defined storage conditions.
Toremifene in Breast Cancer: 20 Years of Endocrine Therapy I
2026-05-03
This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator, for postmenopausal breast cancer. It highlights innovations in personalized endocrine therapy, biomarker-driven approaches, and the nuanced positioning of SERMs relative to steroidal aromatase inhibitors.
InstaBlue Protein Stain Solution: Advancing Quantitative Pro
2026-05-02
Explore how InstaBlue Protein Stain Solution streamlines precise protein quantification in polyacrylamide gels. This article delves into advanced assay integration, mass spectrometry compatibility, and novel insights for translational biomedical research.
TCAIM Controls OGDH Degradation to Fine-Tune Mitochondrial M
2026-05-02
Wang et al. reveal that the mitochondrial co-chaperone TCAIM selectively binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels via HSPA9 and LONP1, thus regulating mitochondrial metabolism in cells and animal models. This discovery uncovers a novel post-translational mechanism with implications for metabolic and neurodegenerative disease research.
Angiotensin I (human, mouse, rat): Advanced Mechanistic Insi
2026-05-01
Explore the unique mechanistic and translational value of Angiotensin I (human, mouse, rat) in renin-angiotensin system research. This article provides an in-depth analysis of the peptide's role, advanced applications, and new assay innovations distinct from previously published protocols.
ML-7 Hydrochloride: Advancing MLCK Inhibition for Translatio
2026-04-30
Explore how ML-7 hydrochloride is redefining the boundaries of myosin light chain kinase (MLCK) inhibition, with mechanistic clarity and actionable guidance for translational researchers. This article delivers a rigorous synthesis of the latest experimental evidence, strategic workflow advice, and a forward-looking vision for leveraging ML-7 in cardiovascular and vascular research.
hly Gene Deletion Impairs Biofilm and Antibiotic Tolerance i
2026-04-30
This study reveals that deletion of the hly gene in Listeria monocytogenes significantly reduces biofilm formation, alters expression of virulence and regulatory genes, and increases sensitivity to ribosome-targeting antibiotics. These findings deepen mechanistic understanding of Listeria persistence and present the hly pathway as a potential intervention target in food safety.
ECL Chemiluminescent Kits: Accelerating Translational Oncolo
2026-04-29
Explore how the APExBIO ECL Chemiluminescent Substrate Detection Kit empowers translational researchers to dissect molecular mechanisms—such as ferroptosis and immune modulation—in cancer models. This article weaves mechanistic insight from recent carbon-ion radiotherapy studies into strategic guidance for optimizing chemiluminescent Western blot and immunoassay workflows, highlighting innovation, reproducibility, and scalability for next-generation oncology research.
Everolimus (RAD001): Optimizing mTOR Inhibition in Cancer As
2026-04-29
Everolimus (RAD001) empowers researchers to dissect mTOR-dependent cancer pathways with precision. This guide translates bench-proven protocols, advanced workflow optimizations, and troubleshooting insights into actionable strategies for apoptosis and proliferation assays, drawing from up-to-date reference studies and rigorously sourced data.
466 records 20/32 page Previous Next First page 上5页 1617181920 下5页 Last page